TRANSLATING INNOVATION PROGRAMS

Translating Innovation Programs are a collection of related projects based at TRI which involve collaboration across institutes, technologies and disciplines, united by a common theme. Of the many translational projects underway at TRI, three key Translating Innovation Programs have been identified.

They each consist of related research projects that are designed to address a clinical need, and develop new or improved interventions or therapeutics to improve health outcomes for patients.

Find out more about these TRI Translating Innovation Programs below.

Immunotherapy

It could be said that TRI was built on immunotherapy, with many of the main translational projects in this program making significant progress - including the cervical cancer and rheumatoid arthritis vaccine projects, which are world-class examples of immunotherapy success.

diagnostic Imaging

Introduced TRI with the appointment of CEO Professor Carolyn Mountford in 2015, this program is a collection of imaging projects using diagnostic imaging techniques to understand the gut/brain axis, pre-cancerous changes to breast tissue in high-risk women, changes to brain chemistry in PTSD, and trauma from blast injury or full contact sports.

> Read more about the Diagnostic Imaging Program at TRI

Microbiome

This Program was established at TRI to address the need to expand our knowledge about the role of the human microbiome in health and disease. 

> View current featured projects at TRI